0IFR Stock Overview
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Ekso Bionics Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.20 |
| 52 Week High | US$3.10 |
| 52 Week Low | US$0.71 |
| Beta | 1.64 |
| 1 Month Change | -13.04% |
| 3 Month Change | -42.08% |
| 1 Year Change | -29.33% |
| 3 Year Change | -78.26% |
| 5 Year Change | n/a |
| Change since IPO | -95.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0IFR | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -9.5% | -1.0% | -0.7% |
| 1Y | -29.3% | -8.5% | -1.8% |
Return vs Industry: 0IFR underperformed the UK Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: 0IFR underperformed the UK Market which returned -2.4% over the past year.
Price Volatility
| 0IFR volatility | |
|---|---|
| 0IFR Average Weekly Movement | 19.1% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0IFR's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0IFR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 71 | Scott Davis | www.eksobionics.com |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
Ekso Bionics Holdings, Inc. Fundamentals Summary
| 0IFR fundamental statistics | |
|---|---|
| Market cap | US$22.92m |
| Earnings (TTM) | -US$15.20m |
| Revenue (TTM) | US$18.28m |
1.2x
P/S Ratio-1.4x
P/E RatioIs 0IFR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0IFR income statement (TTM) | |
|---|---|
| Revenue | US$18.28m |
| Cost of Revenue | US$9.20m |
| Gross Profit | US$9.08m |
| Other Expenses | US$24.28m |
| Earnings | -US$15.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.85 |
| Gross Margin | 49.67% |
| Net Profit Margin | -83.14% |
| Debt/Equity Ratio | 48.2% |
How did 0IFR perform over the long term?
See historical performance and comparison